Accueil cg-1

CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range

Par un écrivain mystérieux
Last updated 05 juillet 2024
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
BrightSpring IPO: KKR-Backed Firm Prices Its $693 Million IPO Below Range - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
IPO Market Warms Up With Busiest US Trading Week Since October - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
A Record Year for IPOs in 2021
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Kyverna Therapeutics' IPO and Recent Successes in Biotech Sector
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
01.25.24 CG sparks IPO hype with supersized $380M raise; Saudi Arabia unveils regional biotech ambitions - Questex
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024 - MedCity News
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Nasdaq Sees IPOs Emerging If Market Holds Before U.S. Election - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
CG Oncology Is Late Stage Looker For Life Science Investors (Pending:CGON)
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Nasdaq Unveils New MarketSite IPO Floor Ahead of Arm, Instacart Debuts - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Cummins Spinoff Atmus Prices IPO at Midpoint to Raise $275 Million - Bloomberg
Recommandé pour vous
Tu pourrais aussi aimer

© 2014-2024 jeevanutthan.in. Inc. ou ses affiliés.